Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -10.42% | -10.95% | -88.75% | -88.21% | 105.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.42% | -10.95% | -88.75% | -88.21% | 105.26% |
| Cost of Revenue | 1.27% | 2.97% | -90.91% | -91.53% | 103.43% |
| Gross Profit | -24.06% | -25.18% | -82.52% | -78.49% | 113.92% |
| SG&A Expenses | 31.42% | -16.54% | -78.67% | -77.13% | 113.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -158.24% | -136.02% | 281.38% | -- | 132.34% |
| Total Operating Expenses | 10.87% | -10.97% | -87.88% | -88.70% | 105.06% |
| Operating Income | -355.52% | -10.74% | -100.00% | -80.37% | 114.81% |
| Income Before Tax | -220.83% | -1,242.83% | -291.56% | -23.26% | 14.65% |
| Income Tax Expenses | -93.89% | -77.00% | -1,578.66% | 72.57% | 165.29% |
| Earnings from Continuing Operations | -286.21% | -1,818.60% | -248.00% | -28.23% | -11.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -183.05% | -340.13% | -247.43% | -28.33% | 648.02% |
| EBIT | -355.52% | -10.74% | -100.00% | -80.37% | 114.81% |
| EBITDA | -281.90% | -78.43% | -96.00% | -85.36% | 128.56% |
| EPS Basic | -177.78% | -333.33% | -241.00% | -30.88% | 429.41% |
| Normalized Basic EPS | -265.49% | -1,244.12% | -- | -- | -67.43% |
| EPS Diluted | -175.16% | -333.33% | -241.00% | -30.88% | 454.12% |
| Normalized Diluted EPS | -265.49% | -1,244.12% | -- | -- | -67.43% |
| Average Basic Shares Outstanding | 6.76% | 2.91% | 4.60% | 3.66% | 0.00% |
| Average Diluted Shares Outstanding | 6.76% | 2.91% | 4.60% | 3.66% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -0.60% |